TATAA Biocenter workshops 2008 (11-Aug-2008 to 30-Dec-2008) TATAA Biocenter develops and performs a broad spectrum of hands-on courses in real-time PCR world-wide, covering all aspects from basic introductory courses for users entering the field of real-time PCR to advanced application based courses, including sample preparation, biostatistics, immuno-qPCR and expression profiling. Welcome to TATAA Biocenter in Göteborg, Freising and Prague. For information on custom made courses and courses at other locations, please visit our website.
Location: Sweden, Germany and Czech Republic
Contact: Henrik Sjöström at henrik.sjostrom@tataa.com or phone +46 31 761 57 04
ClinPhone's webinar series addresses the latest issues facing the clinical trials industry. Attend these webinars and hear from leading industry experts and participate in live Q&A sessions and opinion polls. All the webinars are complimentary, non-commercial and interactive.
Basic & Advanced Randomization Methodologies IVR Tutorials for Study Teams Tues 9 Sept 2008 10am EDT (3pm GMT) Thurs 11 Sept 2008 1pm EDT (6pm GMT)
Automated Trial Supply Management IVR Tutorials for Study Teams Wed 10 Sept 2008 10am EDT (3pm GMT) Tues 16 Sept 2008 1pm EDT (6pm GMT)
From Paper to Web - Implementing a Fully Integrated EDC Solution EDC Tutorials for Study Teams Wed 17 Sept 2008 10am EDT (3pm GMT) Thurs 18 Sept 2008 1pm EDT (6pm GMT)
Optimizing Adaptive Trial Designs - Using Simulation Methodologies to Overcome Challenges Tues 21 October 2008 10am EDT (3pm GMT) Thurs 23 October 2008 1pm EDT (6pm GMT)
Next Generation Integration Tues 9 December 2008 10am EST (3pm GMT) Thurs 11 December 2008 1pm EST (6pm GMT)
For additional information and to register for any of these webinars, please visit www.clinphone.com/webinars.
Registration to the webinars opens one month prior to an event.
I would appreciate it if you could send me a copy/link of the published piece. We would also be delighted if you would like to join the webinar. Please contact us for further information on the webinar.
Many thanks
Fiona Robinson
Fiona Robinson MCIPR The Scott Partnership 1, Whiteside Station Road Holmes Chapel Cheshire CW4 8AA UK Tel: +44 1477 539539 Fax: +44 1477 539540 Email: fer@scottpr.com Web: www.scottpr.com
Regd in England No. 1743203
Location: World Wide
Contact: ClinPhone at or phone
OTAVA Ltd. offers MORE THAN 200 NEW FOCUSED COMPOUND LIBRARIES FOR SCREENING. (12-Sep-2008 to 12-Sep-2009) They include target-specific compound libraries, e.g, P38 kinase inhibitors, cathepsin B inhibitors, HCV serine protease inhibitors and many others as well as libraries with general pharmacological activities, e.g, antiallergic, antiviral, analgesic and other activities. The focused libraries were designed especially for research and development of new lead compounds.
For instance, the libraries include following activities:
…AND MENY OTHERS. Please visit our web-site for a complete list
These focused libraries were prepared by virtual screening using ligand-based approach. Prediction of a specific biological activity is based on analysis of quantitative structure-activity relationships (QSAR) of a training which includes more than 40,000 known biologically active substances. Each library contains only drug-like compounds.
All compounds from our libraries are IN-STOCK and they are available on a cherry-pick basis in vials and/or microplates according to custom specifications. You can also order an entire library.
For these products we offer competitive prices and flexible discounts.
=================================== To receive detailed information on our available target-specific libraries along with their SD/DB files, please contact us:
OTAVA Ltd. 150 Zabolotnogo St. Kyiv, 03143 Ukraine Tel./Fax: +380 44 522 2458 mol.design@otavachemicals.com www.otavachemicals.com ------------------------------------------------------ OTAVA – North American Division 55 Ellerslie Ave., Suite 524 Toronto, Ontario, M2N 1X9 Canada Tel.: 1-416-305-9979 Fax: 1-866-881-9921 (Toll-free in US & Canada) north.america@otavachemicals.com
Lab Manager Bootcamp (22-Oct-2008 to 4-Mar-2009) NEW at Pittcon 2009 - Whether you're a new manager, have some experience or seasoned, Lab Manager Boot Camp will provide lab professionals with the management skills and tools needed to succeed - things they didn't teach you in chemistry class.
Location: Pittcon 2009, Room N427D, McCormick Place, Chicago IL
Contact: Mario Di Ubaldi at mariod@labmanager.com or phone 705-528-6888
CHI’S DRUG FORMULATION (19-Nov-2008 to 20-Nov-2008) This conference will focus on the development of novel drug delivery and formulation systems to create new medicines for the Pharmaceutical Industry. Maximizing bioavailability, improving manufacturability, and enhancing IP protection will be discussed. Industry case studies, posters and discussion groups will high-light advances in this important drug development area. Please join pharmaceutical experts for this in-depth exploration of how to optimize the science and refine the art of small molecule drug formulation. www.healthtech.com
Location: Philadelphia, PA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Oncology Phase III Trials (19-Nov-2008 to 20-Nov-2008) This interactive and informative course provides a comprehensive overview of the planning and implementation of phase III and phase IV oncology clinical trials. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates can learn to design trials to minimize the deficiencies that lead to inappropriate interpretation whilst maximizing the competitive advantage. In addition, delegates will benefit from the perspective and experience of the regulatory bodies on EU oncology directives.
Location: Newark, NJ
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Antibody Engineering (7-Dec-2008 to 11-Dec-2008) This year’s 19th Antibody Engineering International Conference continues to promote interactions within this embryonic field and has become a hallmark of the field, by promoting personal interaction and presenting singular advances in antibody engineering, related binders, and resulting therapeutics, with a dramatic expansion of presentations selected by the Scientific Advisory Board.
Location: Sheraton San Diego Hotel & Marina – San Diego, CA
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
BMD Summit (8-Dec-2008 to 9-Dec-2008) The BMD Summit is the one forum where you can gain in-depth knowledge in two complementary subject areas. Learn the newest uses for disposables, including advantages and limitations, how to apply the best principles for operational excellence to achieve lean manufacturing – or both!
Location: Washington Duke Inn & Golf Club • Durham, NC
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
Intelligent Leadership training for scientists, researchers, engineers, and computer professionals (8-Dec-2008 to 9-Dec-2008) It’s no secret that scientists, researchers, engineers and computer professionals often struggle with leading, communicating and consulting. People who are smart technically can fail or fall far short of expectations when it comes to communicating what they know. And it can be difficult to lead technical people, they tend to not follow orders. At the same time, it’s essential for technical professionals to perform leadership and communications tasks at optimal levels. Their organizations’ success and their own career development depend on the ability of technical professionals to perform at optimum levels in both the technical and leadership and communications aspects of their work.
Location: Cambridge, MA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
IBC's 6th Annual Antibody Therapeutics (9-Dec-2008 to 11-Dec-2008) The 6th Annual Antibody Therapeutics conference is available at no additional charge when you register for Antibody Engineering. You may move freely among the sessions of both events and customize your conference experience to meet the needs of you and your organization. Antibody Therapeutics provides a focused look at the preclinical and clinical development of antibody-based drug products. At this year’s meeting, you will hear updates of preclinical and clinical stage programs, review the current state of the antibody therapeutics market and learn about trends in IP law that could impact your development candidates.
Location: Sheraton San Diego Hotel & Marina – San Diego, CA
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
CHI’S GLP BIOANALYSIS #3 (7-Jan-2009 to 8-Jan-2009) The course will provide detailed information and the current state-of-the-art knowledge on “must know” topics such as writing SOP’s, the do’s and don’ts for the GLP audit, and Quality Assurance.Ample time is allocated to each speaker in order to provide an interactive, in-depth tutorial with time for questions, detailed coverage of the subject and discussion of individual problems and situations. The audience will be strongly encouraged to interact, bring problems, discussion points or suggestions in order to brainstorm with the experts and share new information. You will be provided with printed handouts to follow along with the speakers and take notes.
Location: San Francisco, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
ArabLab 2009 (10-Jan-2009 to 13-Jan-2009) ARABLAB is the No1 Business to Business show for the Analytical Industry and at the forthcoming show, Parker domnick hunter will showcase its range of laboratory gas generators on stand 335.
Location: The Dubai International Convention and Exhibition Centre
Contact: Steve Carss at steve.carss@parker.com or phone 0044 191 4029000
Arab-Lab 2009 (10-Jan-2009 to 13-Jan-2009) ARABLAB is the No1 Business to Business show for the Analytical Industry. The only trade show for the Analytical Industry that reaches buyers from the growth markets... Middle East & Africa... the Indian Sub-Continent... China & Asia.
ARABLAB is the global buying source for tomorrow's technology reaching decision makers and end-users as well as a unique research source focusing on;
Location: Dubai International Convention and Exhibition Centre
Contact: The ARABLAB Group (Scientific International Exhibi at info@arablab.com or phone + 971 4 397 5418
CHI’S PEPTALK (11-Jan-2009 to 16-Jan-2009) • Second Annual Lyophilization 2009 • Inaugural Current Trends in Dosage Form Development & Biologics Formulation • Inaugural Processes to Optimize Protein Purification & Recovery • Inaugural Cell Culture: Fermentation & Media • Second Annual Protein Production • Fifth Annual Protein Therapeutics • Inaugural Antibodies in Translation • Inaugural Implementing the Next Generation of Antibodies • Twelfth Annual Protein Expression • Eighth Annual Protein Diagnostic Development
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
ADME PK/TK and Drug Metabolism in Drug Discovery and Development (20-Jan-2009 to 21-Jan-2009) This course is specifically designed for personnel in the pharmaceutical and biotechnology industries and contract research organizations (CROs) who need to understand the requirements for ADME (absorption, distribution, metabolism, elimination), pharmacokinetics/toxicokinetics (PK/TK) and drug metabolism (DM) experiments during the drug discovery and development processes. Participants should have some knowledge of these processes and desire to learn more about how ADME, PK/TK, and DM studies are designed, conducted, and interpreted in order the characterize the fate of a drug candidate. Nonclinical and clinical scientists, managers, and project team leaders at pharmaceutical companies and related industries will gain a detailed understanding of the types of ADME, PK/TK, and DM research studies conducted to support submissions to regulatory authorities. The content of this course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program that is conducted within a drug development logic plan and in compliance ICH guidelines. The various types of ADME, PK/TK, and DM studies, which include in vitro metabolism and delivery, animal and human pharmacokinetics, protein binding, mass balance, tissue distribution, metabolite isolation and identification, and toxicokinetic support, will be discussed. Study designs and potential results, with possible interpretations, from each of the study types will be presented. The generation study reports and summaries, both of which are to be included in submissions to regulatory authorities, for completed research experiments will be delineated.
Location: Bruss
Contact: Mondial Research Group at cristinah@mondialresearchgroup.com or phone 0044 208 144 7170
Stem Cells World Congress (20-Jan-2009 to 22-Jan-2009) Welcome to the 3rd annual Stem Cells World Congress. This year's event will be held in beautiful Palm Springs, California - definitely the place to be in January! The conference will be co-located with the World Biobanking Summit. Registered delegates will have access to both meetings ensuring a very cost-effective trip.
Location: Palm Springs, California
Contact: Sara Sharpe at s.sharpe@selectbiosciences.com or phone 01787 315110
Predictive Human Toxicity and ADME/Tox Studies (22-Jan-2009 to 23-Jan-2009) Following the success of previous years, Mondial Research Group is proud to present it's 4th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies and looks to build on a growing reputation as it becomes the defacto meeting of its kind.
Mondial Research Group along with its strategic partners will bring together scientific experts to present and discuss the most recent advances towards accurately predicting human toxicities, and how to implement successful screening earlier in the drug discovery process. This event will cover topics on toxicogenomics, in-silico tools, ADME, Toxicology and Pharmacokinetics and much more.
CHI’S BIOMARKER ASSAY DEVELOPMENT (26-Jan-2009 to 28-Jan-2009) The increasing importance of biomarkers in the drug discovery process calls for a comprehensive biomarker strategy that must include assay development and validation. CHI’s Inaugural Biomarker Assay Development meeting addresses “fit-for-purpose” method development, spanning pre-clinical and clinical drug development, as well as diagnostics. The meeting will provide an overview of novel assay platforms for genomic and proteomic analysis, as well as multiplexed assays, flow cytometry, and more. It will also discuss the pros and cons of developing the assay in-house vs. adopting off-the-shelf solutions/kits vs. outsourcing. And finally, since the meeting is co-located with the Translational Cancer Medicine meeting, it will also focus on biomarker assays in oncology.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S TRANSLATIONAL CANCER MEDICINE (26-Jan-2009 to 28-Jan-2009) The increasing technological advances in biomarker and target discovery, pre-clinical models, personalized medicine, and clinical trial design have the potential to expedite the translation of new discoveries to clinical practice. Oncology is the area that has perhaps benefited the most from these new technologies. The Translational Cancer Medicine meeting will identify the key opportunities to improve cancer diagnosis and treatment, as well as provide case studies of successful (and not so successful) drug development. The pre-conference workshop will provide a comprehensive survey of novel cancer biomarkers. Translational Cancer Medicine is co-located with the Biomarker Assay Development meeting.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Orphan Diseases (5-Feb-2009 to 6-Feb-2009) IBC's Inaugural Orphan Diseases conference is the premier conference to attend if you are involved or interested in research and discovery, drug development, clinical trials, regulatory affairs, funding or the commercialization of orphan disease therapies and cures.
Location: Hyatt Regency Bethesda * Bethesda, MD
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
Location: Ft. Lauderdale, FL
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
ADMET Europe (23-Feb-2009 to 25-Feb-2009) The 2nd annual ADMET Europe conference will be held in Berlin, Germany. Co-located with Screening Europe and MedChem Europe, and sharing an exhibition, registration will allow access to all 3 meetings, ensuring a very cost-effective trip.
MedChem Europe (23-Feb-2009 to 25-Feb-2009) The 5th annual MedChem Europe conference will be held in Berlin, Germany. Co-located with Screening Europe and ADMET Europe, and sharing an exhibition, registration will allow access to all 3 meetings. To accommodate even more talks this year the SE and MC conferences will be extended to 3 days.
Location: Berlin
Contact: Helen Read at h.read@Selectbiosciences.com or phone +44 (0) 1787 315110
Screening Europe (23-Feb-2009 to 25-Feb-2009) The 6th annual Screening Europe conference will be held in Berlin, Germany. Co-located with MedChem Europe and ADMET Europe, and sharing an exhibition, registration to SE will allow access to all 3 meetings. To accommodate even more talks this year the SE and MC conferences will be extended to 3 days.
Location: Berlin
Contact: Helen Read at h.read@Selectbiosciences.com or phone +44 (0) 1787 315110
TIDESAsia (23-Feb-2009 to 25-Feb-2009) IBC's Inaugural AsiaTIDES is the only event that brings worldwide best practices in development strategies for oligonucleotide and peptide-based therapeutics including formulation and delivery, and regulatory updates—to Japan.
Location: Sheraton Miyako Hotel * Tokyo, Japan
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800)390-4078
CHI’S MOLECULAR MEDICINE TRI-CONFERENCE (24-Feb-2009 to 27-Feb-2009) The Fifteenth International Molecular Medicine Tri-Conference delivered the hottest areas of biotechnology brought together in one location. Molecular Diagnostics, Medicinal Chemistry, Stem Cells and Translational Medicine were the buzz at this year’s event. The presenters delivered pragmatic and solution-driven insights that captivated the audience and the exhibit hall delivered more technologies than ever before. Attendance hit historic levels reaching 2800 delegates for first time. The continued growth of the event is a strong indicator that the confluence of biology, chemistry and business is being realized.
Location: San Francisco, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Drug Discovery Latin America (26-Feb-2009 to 27-Feb-2009) The inaugural Drug Discovery Latin America conference and exhibition; to review the status of drug discovery activities in Latin America and to assist its future development. Business and research leaders from developed markets and BRIC countries will bring their knowledge and experience to share.
Location: Rio de Janeiro
Contact: Stephen Mudd at s.mudd@Selectbiosciences.com or phone +44 (0) 1787 315110
CHI’S THE GREENING OF PHARMA (2-Mar-2009 to 3-Mar-2009) This premier CHI “Greening of BioPharma” Conference creates a unique forum bringing together, in one place, BioPharmaceutical company Real Estate Executives, Engineers, and Laboratory and Manufacturing Facilities Management Executives and Senior Managers with leading BioPharmaceutical laboratory and manufacturing facilities architects, construction firms, biopharmaceutical process design and systems companies and equipment vendors to define the future of “The Greening of BioPharma”. This conference will address the specialized issues and challenges unique to the Biotech and Pharmaceutical industries and how leading companies have met these challenges.
Location: Boston, MA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Location: La Costa Resort and Spa, Carlsbad, CA
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
Pittcon (8-Mar-2009 to 13-Mar-2009) Pittcon is the premier conference and exposition on laboratory sciences and the most comprehensive annual meeting on laboratory science in the world. Parker domnick hunter will be exhibiting at the forthcoming event.
Location: McCormick Place, Chicago, IL, USA
Contact: Jane Sexton at jane.sexton@parker.com or phone
CHI’S DRUG DEVELOPMENT LATIN AMERICA (9-Mar-2009 to 10-Mar-2009) The globalization of R&D into emerging regions continues. Growing R&D spending in these regions has been driven by many factors including the attractiveness of commercial markets there, more favorable economics including lower relative costs for greater speed, access to highly skilled professional labor and a large pool of patients, particularly treatment-naïve ones.
Location: Miami, FL
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S ELECTRONIC DATA IN CLINICAL TRIALS (11-Mar-2009 to 12-Mar-2009) New technology is available and being created everyday to make the collection, correction and assessment of data from clinical trials more efficient. How do you decide which technology to use and when to use it? What are the common problems with implementation and how do you resolve them. This inaugural conference is being organized to address these issues.
Location: Miami, FL
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Protein Purification: Principles & Practice (15-Mar-2009 to 20-Mar-2009) A 5 ½ day hands-on laboratory course in which participants will learn skills to effectively design separation and purification strategies for downstream processing. This course uses the remarkable Green-Fluorescent Protein (GFP), a novel marker for gene expression, as the source material. While this is a general course applicable to all proteins, we use GFP as a highly effective visual teaching tool. More than 1200 scientists from around the world have strongly recommended this intensive course as an opportunity to develop protein research and analytical skills in a retreat setting. Participants work hard, identify and solve problems in the lab and enjoy camaraderie and good food and drink with colleagues. This five and one half day laboratory course covers a wide variety of conventional methods for protein isolation, purification, and characterization. The course format integrates hands-on laboratory exercises with classroom lectures, demonstrations, study breaks, and short take-home assignments.
Location: New Brunswick, NJ
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S COMPREHENDING COPY NUMBER VARIATION (16-Mar-2009 to 17-Mar-2009) All agree that copy number variation (CNV) contributes substantially to human genetic diversity. But to what extent? The resulting applications of newly developed whole-genome scanning technologies have catalyzed the appreciation of CNV in the genetic community. The range of these promising new technologies will, for the first time, allow scanning of the entire human genome for CNV in a single experiment. As these genome-wide scanning techniques become more widely used in diagnostic laboratories, the major challenge is how to accurately interpret which submicroscopic genomic imbalances are pathogenic in nature and which are benign.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S QUANTITATIVE PCR (16-Mar-2009 to 17-Mar-2009) PCR’s sensitivity, specificity, and simplicity has revolutionized molecular biology in basic, industrial, and clinical settings. Technologies abound including quantitative PCR (qPCR), multiplex qPCR, real-time PCR, and reverse transcription quantitative PCR (RT-qPCR). Your technology selection is determined by the source of nucleic acid. However, complexities arise because of multiple assays, numerous protocols, abundant sources, lack of assay standardization, differences in sample processing, ineffective use of controls, normalization methods, and quality control management. Researchers face challenges in reliability, relevance, and reproducibility. Learn from savvy, seasoned researchers as they share their real-world experiences, applications, and results at Cambridge Healthtech Institute’s 5th Annual Quantitative PCR.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S NEXT-GENERATION SEQUENCING (18-Mar-2009 to 19-Mar-2009) Next-generation sequencing is driving growth within the basic and biomedical research community as rapidly as the bases are being sequenced. All agree however, with the implementation of any new technology there is a balancing act of cost-quality-quantity. What is your sequencing goal? The potential applications are as numerous as the samples to be analyzed. Each next-gen platform is optimized for specific sequencing applications. Cambridge Healthtech Institute’s 3rd Annual Next-Generation Sequencing offers an unparalleled opportunity to compare and contrast the next-generation sequencing platforms to best suit your research needs.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S THE CHALLENGE OF ANTIBACTERIAL DRUG DEVELOPMENT (18-Mar-2009 to 19-Mar-2009) Resistant bacterial strains are becoming an increasing challenge for the pharmaceutical industry. There is a growing need to develop novel defense mechanisms and novel strategies to treat bacterial infections. In recent years, scientists have focused increasingly on developing novel concepts and improving leads to overcome the challenge of resistance. The interaction of biology and chemistry is key to the solution of this problem.
Location: San Diego, CA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
CHI’S MICRORNA IN HUMAN DISEASE AND DEVELOPMENT (23-Mar-2009 to 25-Mar-2009) Although microRNAs were brought into the spotlight only recently, their role in regulating mammalian development and disease has become clear. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. Cambridge Healthtech Institute’s Fifth Annual microRNA in Human Disease and Development meeting is specifically designed to address the role of miRNA in human development and disease, and to explore the impact of this new research for drug and diagnostic development. The meeting will cover progress in identifying human miRNA, technologies used for miRNA profiling, and the latest research in linking miRNA to human disease. Opportunities for using miRNA as diagnostic biomarkers and a novel class of targets for therapeutic development will be explored.
Location: Boston, MA
Contact: CHI Representative at chi@healthtech.com or phone 781 972 5400
Location: Courtyard Boston Downtown Tremont Hotel * Boston, MA
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
China R&D Summit (6-Apr-2009 to 8-Apr-2009) Integrate China into your global strategy – from R&D to clinical trials. Hear first-time case studies, industry insights and exciting panel discussions on controversial topics to help you leverage China as your global partner in licensing, outsourcing or joint research and development.
Location: Grand Hyatt Hotel • Shanghai China
Contact: IBC Asia Customer Service at enquiry@ibcasia.com.sg or phone +65 6835 5136
Advances in Synthetic Chemistry (16-Apr-2009 to 17-Apr-2009) Welcome to the 2nd annual Advances in Synthetic Chemistry conference and exhibition. This year's event will be held in the beautiful and historic city of Edinburgh.
Advances in Synthetic Biology (28-Apr-2009 to 29-Apr-2009) Welcome to the Advanced Synthetic Biology conference and exhibition. Synthetic biology is the design and construction of new biological parts, devices and systems (and the re-design of existing, natural biological systems) for useful purposes.
Location: London
Contact: Sam Marsden at s.marsden@selectbiosciences.com or phone +44(0)1787 315120
Location: Estancia La Jolla Resort * La Jolla, CA
Contact: IBC Customer Service at reg@ibcusa.com or phone (800) 390-4078
DxRx Summit (12-May-2009 to 13-May-2009) Welcome to the Nucleic Acid Diagnostics & Therapeutics Summit. This inaugural summit will be be held in Boston, MA immediately prior to the annual RNAi World Congress, which will address the latest research in RNAi and microRNA research.
RNAi World Congress (14-May-2009 to 15-May-2009) Welcome to the 3rd annual RNAi World Congress. This year's event will be held in Boston, home to many of the world's top institutions engaged in gene silencing research.
Location: Boston, MA
Contact: Helen Read at h.read@selectbiosciences.com or phone +44 (0)1787 315110
TIDES: Oligonucleotide and Peptide® Technology and Product Development (17-May-2009 to 20-May-2009) Join 600+ attendees at the conference that addresses manufacturing technologies for oligonucleotide and peptide-based technologies, as well as drug development strategies to help you accelerate your product development
Location: Red Rock Casino, Resort and Spa • Las Vegas, NV
Contact: IBC Customer Service at reg@ibcusa.com or phone (800) 390-4078
Advances in Microarray Technology (19-May-2009 to 20-May-2009) Welcome to the 5th annual Advances in Microarray Technology (AMT) conference where you will hear about the latest developments and applications in the rapidly expanding field of microarrays.
Location: Stockholm
Contact: Sara Sharpe at s.sharpe@selectbiosciences.com or phone +44 (0)1787 315110
Lab-on-a-Chip European Congress (19-May-2009 to 20-May-2009) Welcome to the 3rd annual Lab-on-a-Chip European Congress, designed to review existing and new life science applications of microfluidic technologies.
Location: Stockholm
Contact: Sara Sharpe at s.sharp@selectbiosciences.com or phone +44 (0) 1787 315110
Molecular Diagnostics Europe (19-May-2009 to 20-May-2009) Welcome to the inaugural Molecular Diagnostics Europe conference. Agenda Topics may include: Trends and Emerging Technologies in Molecular Diagnostics, PGx and Personalized Medicine.
Location: Stockholm
Contact: Sara Sharpe at s.sharpe@selectbiosciences.com or phone +44 (0)1787 315110
Location: Keio Plaza Hotel * Tokyo, Japan
Contact: IBC Asia Customer Service at info@ibcasia.com.sg or phone +65 6835 5136
Cancer Proteomics (8-Jun-2009 to 11-Jun-2009) Organized in association with UCD and supported by EMBO, the aim is to create a translational framework by which proteomics investigations can advance our knowledge of cancer-related processes and ultimately be utilized in a clinical context.
Cell Line Development and Engineering (22-Jun-2009 to 24-Jun-2009) Increased demand to maximize protein expression levels is driving the need for scientists to quickly identify the best cell lines and work together with engineers to develop, integrate and optimize the most robust processes. IBC's 3rd Cell Line Development and Engineering event is the only industry forum that brings together forward-thinking academics with industry leaders to report on the latest advances that are occurring during every stage of the process from molecular biology through manufacturing.
Location: Hilton La Jolla Torrey Pines • La Jolla, CA
Contact: IBC Customer Service at reg@ibcusa.com or phone (800) 390-4078
AgriGenomics World Congress (2-Jul-2009 to 3-Jul-2009) Welcome to the second annual AgriGenomics World Congress. AgriGenomics is the detailed study of the genetic makeup of the plant and how all the genes work together to produce the crop.
Location: London
Contact: Sam Marsden at s.marsden@selectbiosciences.com or phone +44(0)1787 315120
Location: World Trade Center Boston & Seaport Hotel -- Boston, MA
Contact: IBC Life Sciences at reg@ibcusa.com or phone (800) 390-4078
Target Discovery World Congress (4-Aug-2009 to 5-Aug-2009) Welcome to the Target Discovery World Congress, combining our successful Screening and Ion Channel Targets conferences
Location: South San Francisco, CA
Contact: Helen Read at h.read@selectbiosciences.com or phone +44(0)1787 315112
Lab-on-a-Chip World Congress (6-Aug-2009 to 7-Aug-2009) Welcome to the Lab-on-a-Chip World Congress, designed to review existing and new life science applications of microfluidic technologies.
Microarray World Congress (6-Aug-2009 to 7-Aug-2009) Welcome to the Microarray World Congress where you will hear about the latest developments and applications in the rapidly expanding field of microarrays.
Molecular Diagnostics World Congress (6-Aug-2009 to 7-Aug-2009) Welcome to the 2nd Molecular Diagnostics World Congress which will be co-located with the Microarray World Congress and Lab-on-a-Chip World Congress
Location: South San Francisco, CA
Contact: Sara Sharpe at s.sharpe@selectbiosciences.com or phone +44(0)1787 314956
Advances in qPCR (17-Sep-2009 to 18-Sep-2009) Welcome to the 2nd annual Advances in qPCR conference and exhibition. The conference will be co-located with RNAi Europe, Peptides Europe and the Epigenetics World Congress.
Location: Berlin
Contact: Helen Read at h.read@selectbiosciences.com or phone +44(0)1787 315112
Epigenetics World Congress (17-Sep-2009 to 18-Sep-2009) Welcome to the inaugural Epigenetics World Congress. The conference will be co-located with the Advances in qPCR, Peptides Europe and RNAi Europe conferences.
Location: Berlin
Contact: Helen Read at h.read@selectbiosciences.com or phone +44(0)1787 314956
Peptides Europe (17-Sep-2009 to 18-Sep-2009) Welcome to the inaugural Peptides Europe conference and exhibition. The conference will be co-located with RNAi Europe, Advances in qPCR, and the Epigenetics World Congress.
Location: Berlin
Contact: Helen Read at h.read@selectbiosciences.com or phone +44(0)1787 315120
RNAi Europe (17-Sep-2009 to 18-Sep-2009) Welcome to the 6th annual RNAi Europe - Europe's largest conference & exhibition dedicated to RNA interference. The conference will be co-located with Advances in qPCR, Peptides Europe, and the Epigenetics World Congress.
Location: Berlin
Contact: Helen Read at h.read@selectbiosciences.com or phone +44(0)1787 315120
BioProcess International™ Conference & Exhibition (12-Oct-2009 to 16-Oct-2009) BioProcess International™ is THE meeting place for the bioprocessing industry.
Location: Raleigh Convention Center * Raleigh, NC
Contact: IBC Customer Service at reg@ibcusa.com or phone (800) 390-4078